Axar.az
UP

Pfizer COVID-19 vaccine wins full U.S. FDA approval

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The U.S. drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, making it the first to secure such Food and Drug Administration validation as health authorities struggle to win over vaccine skeptics during a relentless pandemic.

Axar.az reports that the FDA, which gave the two-dose vaccine emergency-use authorization in December, gave its full approval for use in people age 16 and older based on updated data from the companies' clinical trial and manufacturing review. Public health officials hope the action will convince unvaccinated Americans that Pfizer's shot is safe and effective.

There is entrenched vaccine skepticism among some Americans, particularly conservatives. COVID-19 cases, driven by the highly infectious Delta variant, have surged in parts of the United States with lower vaccination levels.

"This FDA approval should give added confidence that this vaccine is safe and effective," President Joe Biden, who has sought to increase vaccination levels, wrote on Twitter.

Date
2021.08.23 / 23:14
Author
Axar.az
Comments
See also

Pfizer has withdrawn a drug at risk for cancer

China administers over 2 bln COVID-19 vaccine doses

EU and AstraZeneca reach deal to end vaccine row

A new strain of the coronavirus is spreading - WHO

Delta variant patients twice as likely need hospital care

5 billion doses of vaccine have been given worldwide

American expert`s pessimistic statement about COVID-19

Pfizer seen reaping billions from COVID-19 vaccine market

WHO sees possibility of naming new coronavirus strains

Pfizer and Moderna vaccines have risen in price

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla